Literature DB >> 21298356

Rectal cancer: 3D dynamic contrast-enhanced MRI; correlation with microvascular density and clinicopathological features.

W W Yao1, H Zhang, B Ding, T Fu, H Jia, L Pang, L Song, W Xu, Q Song, K Chen, Z Pan.   

Abstract

PURPOSE: The primary aim of this prospective study was to evaluate the relationship between three-dimensional dynamic contrast-enhanced magnetic resonance (3D-DCE-MR) imaging parameters and clinicopathological features of rectal cancer and assess their potential as new radiological prognostic predictors.
MATERIALS AND METHODS: Three-dimensional DCE-MR was performed on 26 cases of pathologically proved rectal adenocarcinoma 1 week prior to operation. Data were analysed to calculate transfer constant (Ktrans), leakage space (Ve) and rate constant (Kep) of both tumour and normal rectal wall. Microvessel density (MVD) was evaluated by immunohistochemical staining of surgical specimens. All findings were analysed prospectively and correlated with tumour/node/metastasis (TNM) staging, Dukes staging, histological grading, presence of lymph node metastasis, serosal involvement and MVD.
RESULTS: Mean Ktrans, Ve and Kep for tumours were as follows: Ktrans 7.123±3.850/min, Ve 14.2±3.0%, Kep 49.446±20.404/min, revealing the significant difference between the tumour and normal rectal wall (p=0.001). There was a significant difference for Ktrans not only between patients with and without lymphatic involvement (p=0.000), but also among Dukes staging (p=0.04) and pTNM staging (p=0.03). Kep showed moderate correlation with TNM stages (r=0.479, p=0.02). Ve and MVD revealed no significant correlation with the clinicopathological findings described above (p>0.05).
CONCLUSION: Owing to the moderate and strong relationship between Ktrans and clinicopathological elements, Ktrans might be the prognostic indicator of rectal cancer. Threedimensional DCE high-resolution MR imaging provides a competing opportunity to assess contrast kinetics.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21298356     DOI: 10.1007/s11547-011-0628-2

Source DB:  PubMed          Journal:  Radiol Med        ISSN: 0033-8362            Impact factor:   3.469


  37 in total

Review 1.  Preoperative staging of rectal cancer.

Authors:  Neil Smith; Gina Brown
Journal:  Acta Oncol       Date:  2008       Impact factor: 4.089

Review 2.  Modeling tracer kinetics in dynamic Gd-DTPA MR imaging.

Authors:  P S Tofts
Journal:  J Magn Reson Imaging       Date:  1997 Jan-Feb       Impact factor: 4.813

3.  Dynamic TurboFLASH subtraction technique for contrast-enhanced MR imaging of the prostate: correlation with histopathologic results.

Authors:  G J Jager; E T Ruijter; C A van de Kaa; J J de la Rosette; G O Oosterhof; J R Thornbury; S H Ruijs; J O Barentsz
Journal:  Radiology       Date:  1997-06       Impact factor: 11.105

4.  Colorectal cancer in Guangdong Province of China: a demographic and anatomic survey.

Authors:  An-Gao Xu; Zhi-Jin Yu; Bo Jiang; Xin-Ying Wang; Xu-Hui Zhong; Ji-Hong Liu; Qiu-Yun Lou; Ai-Hua Gan
Journal:  World J Gastroenterol       Date:  2010-02-28       Impact factor: 5.742

5.  Techniques and trouble-shooting in high spatial resolution thin slice MRI for rectal cancer.

Authors:  G Brown; I R Daniels; C Richardson; P Revell; D Peppercorn; M Bourne
Journal:  Br J Radiol       Date:  2005-03       Impact factor: 3.039

6.  Role of angiogenesis in benign, premalignant and malignant vulvar lesions.

Authors:  A B MacLean; W M Reid; K J Rolfe; S J Gammell; H E Pugh; K C Gatter; A C Wong Te Fong; J C Crow; C W Perrett
Journal:  J Reprod Med       Date:  2000-08       Impact factor: 0.142

Review 7.  Functional imaging of colorectal cancer angiogenesis.

Authors:  Vicky Goh; Anwar R Padhani; Shahnawaz Rasheed
Journal:  Lancet Oncol       Date:  2007-03       Impact factor: 41.316

8.  Primary signet-ring cell carcinoma of the colon and rectum.

Authors:  T Anthony; R George; M Rodriguez-Bigas; N J Petrelli
Journal:  Ann Surg Oncol       Date:  1996-07       Impact factor: 5.344

9.  Prognostic significance of the microvascular count in colorectal cancer.

Authors:  G Lindmark; B Gerdin; C Sundberg; L Påhlman; R Bergström; B Glimelius
Journal:  J Clin Oncol       Date:  1996-02       Impact factor: 44.544

10.  Tumor angiogenesis and rectal carcinoma.

Authors:  T J Saclarides; N J Speziale; E Drab; D J Szeluga; D B Rubin
Journal:  Dis Colon Rectum       Date:  1994-09       Impact factor: 4.585

View more
  14 in total

1.  Contrast-enhanced dynamic and diffusion-weighted magnetic resonance imaging at 3.0 T to assess early-stage nasopharyngeal carcinoma.

Authors:  Liangping Ni; Ying Liu
Journal:  Oncol Lett       Date:  2018-02-05       Impact factor: 2.967

2.  Dynamic contrast-enhanced magnetic resonance imaging for characterising nasopharyngeal carcinoma: comparison of semiquantitative and quantitative parameters and correlation with tumour stage.

Authors:  Bingsheng Huang; Chun-Sing Wong; Brandon Whitcher; Dora Lai-Wan Kwong; Vincent Lai; Queenie Chan; Pek-Lan Khong
Journal:  Eur Radiol       Date:  2013-02-02       Impact factor: 5.315

3.  Correlation of tumor characteristics derived from DCE-MRI and DW-MRI with histology in murine models of breast cancer.

Authors:  Stephanie L Barnes; Anna G Sorace; Mary E Loveless; Jennifer G Whisenant; Thomas E Yankeelov
Journal:  NMR Biomed       Date:  2015-08-30       Impact factor: 4.044

4.  Improved detection of a tumorous involvement of the mesorectal fascia and locoregional lymph nodes in locally advanced rectal cancer using DCE-MRI.

Authors:  Marco Armbruster; Melvin D'Anastasi; Veronika Holzner; Martin E Kreis; Olaf Dietrich; Bernhard Brandlhuber; Anno Graser; Martina Brandlhuber
Journal:  Int J Colorectal Dis       Date:  2018-05-17       Impact factor: 2.571

5.  Perfusion parameters of dynamic contrast-enhanced magnetic resonance imaging in patients with rectal cancer: correlation with microvascular density and vascular endothelial growth factor expression.

Authors:  Yeo-Eun Kim; Joon Seok Lim; Junjeong Choi; Daehong Kim; Sungmin Myoung; Myeong-Jin Kim; Ki Whang Kim
Journal:  Korean J Radiol       Date:  2013-11-05       Impact factor: 3.500

6.  Comparison between the Prebolus T1 Measurement and the Fixed T1 Value in Dynamic Contrast-Enhanced MR Imaging for the Differentiation of True Progression from Pseudoprogression in Glioblastoma Treated with Concurrent Radiation Therapy and Temozolomide Chemotherapy.

Authors:  J G Nam; K M Kang; S H Choi; W H Lim; R-E Yoo; J-H Kim; T J Yun; C-H Sohn
Journal:  AJNR Am J Neuroradiol       Date:  2017-10-26       Impact factor: 3.825

7.  Quantitative dynamic contrast-enhanced and diffusion-weighted MRI for differentiation between nasopharyngeal carcinoma and lymphoma at the primary site.

Authors:  Xiao-ping Yu; Jing Hou; Fei-ping Li; Wang Xiang; Qiang Lu; Yin Hu; Hui Wang
Journal:  Dentomaxillofac Radiol       Date:  2016-02-05       Impact factor: 2.419

Review 8.  Dynamic contrast-enhanced (DCE) imaging: state of the art and applications in whole-body imaging.

Authors:  Domenico Albano; Federico Bruno; Andrea Agostini; Salvatore Alessio Angileri; Massimo Benenati; Giulia Bicchierai; Michaela Cellina; Vito Chianca; Diletta Cozzi; Ginevra Danti; Federica De Muzio; Letizia Di Meglio; Francesco Gentili; Giuliana Giacobbe; Giulia Grazzini; Irene Grazzini; Pasquale Guerriero; Carmelo Messina; Giuseppe Micci; Pierpaolo Palumbo; Maria Paola Rocco; Roberto Grassi; Vittorio Miele; Antonio Barile
Journal:  Jpn J Radiol       Date:  2021-12-24       Impact factor: 2.374

9.  Quantitative analysis of 3-Tesla magnetic resonance imaging in the differential diagnosis of breast lesions.

Authors:  Zhen-Shen Ma; DA-Wei Wang; Xiu-Bin Sun; Hao Shi; Tao Pang; Gui-Qing Dong; Cheng-Qi Zhang
Journal:  Exp Ther Med       Date:  2014-12-22       Impact factor: 2.447

10.  Practical dynamic contrast enhanced MRI in small animal models of cancer: data acquisition, data analysis, and interpretation.

Authors:  Stephanie L Barnes; Jennifer G Whisenant; Mary E Loveless; Thomas E Yankeelov
Journal:  Pharmaceutics       Date:  2012       Impact factor: 6.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.